EI

263.5

-1.24%↓

SAN

85.4

-1.42%↓

MRK1

107.75

-0.19%↓

ARGX

602.4

-1.31%↓

FRE

46.29

-0.75%↓

EI

263.5

-1.24%↓

SAN

85.4

-1.42%↓

MRK1

107.75

-0.19%↓

ARGX

602.4

-1.31%↓

FRE

46.29

-0.75%↓

EI

263.5

-1.24%↓

SAN

85.4

-1.42%↓

MRK1

107.75

-0.19%↓

ARGX

602.4

-1.31%↓

FRE

46.29

-0.75%↓

EI

263.5

-1.24%↓

SAN

85.4

-1.42%↓

MRK1

107.75

-0.19%↓

ARGX

602.4

-1.31%↓

FRE

46.29

-0.75%↓

EI

263.5

-1.24%↓

SAN

85.4

-1.42%↓

MRK1

107.75

-0.19%↓

ARGX

602.4

-1.31%↓

FRE

46.29

-0.75%↓

Search

Siemens Healthineers AG

Gesloten

SectorGezondheidszorg

47.28 0.04

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

47.06

Max

47.61

Belangrijke statistieken

By Trading Economics

Inkomsten

15M

552M

Verkoop

-247M

5.7B

K/W

Sectorgemiddelde

24.632

35.724

EPS

0.64

Dividendrendement

1.98

Winstmarge

9.749

Werknemers

73,500

EBITDA

64M

1.2B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+27.85% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.98%

3.09%

Volgende Winsten

25 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-370M

53B

Vorige openingsprijs

47.24

Vorige sluitingsprijs

47.28

Nieuwssentiment

By Acuity

32%

68%

79 / 372 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Siemens Healthineers AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 jul 2025, 05:43 UTC

Winsten

Siemens Healthineers Narrows Target Ranges, Raises Midpoints

7 mei 2025, 05:31 UTC

Winsten

Siemens Healthineers Posts Profit, Revenue Rise; Adjusts Guidance on Tariff Uncertainty

2 apr 2025, 20:00 UTC

Acquisities, Fusies, Overnames

Siemens Agrees to Buy Dotmatics for $5.1 Billion, Expanding AI Portfolio to Life Sciences -- Update

2 apr 2025, 19:07 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Siemens Agrees to Buy Software Company Dotmatics for $5.1 Billion

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers Now Sees Comparable Rev Growth Between 5.5%-6% Vs 5%-6% Previously

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers Raise Midpoints of FY25 Target Ranges

30 jul 2025, 05:02 UTC

Winsten

Analysts Saw Siemens Healthineers 3Q Adj Ebit at EUR883M

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers Narrows FY25 Target Ranges for Rev Growth, Adjusted Basic EPS

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers Now Sees Adj Basic EPS Between EUR2.30-EUR2.45 Vs EUR2.20-EUR2.50 Previously

30 jul 2025, 05:02 UTC

Winsten

Analysts Saw Siemens Healthineers 3Q Adj Ebit Margin of 15.8%

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers 3Q Adj Ebit Margin 16.8%

30 jul 2025, 05:02 UTC

Winsten

Analysts Saw Siemens Healthineers 3Q Revenue at EUR5.61B

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers 3Q Net Pft EUR556M

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers 3Q Rev EUR5.66B

30 jul 2025, 05:02 UTC

Winsten

Siemens Healthineers 3Q Adj Ebit EUR953M

7 mei 2025, 07:14 UTC

Marktinformatie
Winsten

Siemens Healthineers' Imaging Segment Delivered a Strong Quarter -- Market Talk

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers 2Q Adj EBIT EUR982M

7 mei 2025, 05:00 UTC

Winsten

Analysts Saw Siemens Healthineers 2Q Adj EBIT at EUR941M

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers Sees 2025 Comp Rev Growth At 5% - 6%

7 mei 2025, 05:00 UTC

Winsten

Analysts Saw Siemens Healthineers 2Q Net Profit at EUR537M

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers Now Sees 2025 Adj EPS of EUR2.20 - EUR2.50

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers 2Q Net Pft EUR537M

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers Had Guided For Adj EPS of EUR2.35 - EUR2.50

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers 2Q Adj EBIT margin 16.6%

7 mei 2025, 05:00 UTC

Winsten

Analysts Saw Siemens Healthineers 2Q Rev at EUR5.79B

7 mei 2025, 05:00 UTC

Winsten

Siemens Healthineers 2Q Rev EUR5.91B

2 apr 2025, 19:45 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Siemens Agrees to Buy Dotmatics for $5.1B, Expanding AI Portfolio to Life Sciences -- Update

2 apr 2025, 18:52 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Siemens Agrees to Buy Software Company Dotmatics for $5.1B

27 mrt 2025, 11:21 UTC

Marktinformatie
Acquisities, Fusies, Overnames

ProSiebenSat.1's Stock Seen With Speculative Appeal Amid MFE's Takeover Bid -- Market Talk

27 mrt 2025, 11:05 UTC

Marktinformatie
Acquisities, Fusies, Overnames

MFE's ProSiebenSat.1 Bid Seen as Attempt to Avoid Pricier Mandatory Takeover -- Market Talk

Peer Vergelijking

Prijswijziging

Siemens Healthineers AG Prognose

Koersdoel

By TipRanks

27.85% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 60.332 EUR  27.85%

Hoogste 65.426 EUR

Laagste 50.327 EUR

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Siemens Healthineers AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Technische score

By Trading Central

45.88 / 46.84Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Very Strong Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

79 / 372 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.